The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Extension of overall survival (OS) beyond objective responses (OR) in patients (pts) with metastatic renal cell carcinoma (mRCC) treated with high dose interleukin-2 (HD IL-2).
 
David D. Stenehjem
No Relationships to Disclose
 
Michael Toole
No Relationships to Disclose
 
Joseph Merriman
No Relationships to Disclose
 
Kinjal Parikh
No Relationships to Disclose
 
Stephanie Daignault
No Relationships to Disclose
 
Sarah Scarlett
No Relationships to Disclose
 
Peg Esper
No Relationships to Disclose
 
Katherine Skinner
No Relationships to Disclose
 
Aaron Udager
No Relationships to Disclose
 
Srinivas Kiran Tantravahi
No Relationships to Disclose
 
Alli M. Straubhar
No Relationships to Disclose
 
Archana M. Agarwal
No Relationships to Disclose
 
Joan Van Atta
No Relationships to Disclose
 
Kenneth F. Grossmann
Consulting or Advisory Role - Roche/Genentech
 
Wolfram E. Samlowski
No Relationships to Disclose
 
Bruce G. Redman
No Relationships to Disclose
 
Neeraj Agarwal
No Relationships to Disclose
 
Ajjai Shivaram Alva
Honoraria - Eisai
Consulting or Advisory Role - Eisai
Research Funding - BIND Biosciences; Bristol-Myers Squibb; Genentech; Novartis; Oncogenex